Pages that link to "Q33995847"

The following pages link to Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin (Q33995847):

Displaying 44 items.

• Structure of heptameric protective antigen bound to an anthrax toxin receptor: a role for receptor in pH-dependent pore formation (Q24301840) (← links)
• Receptor-specific requirements for anthrax toxin delivery into cells (Q24532114) (← links)
• Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins (Q24562788) (← links)
• Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process (Q24675885) (← links)
• The Protective Antigen Component of Anthrax Toxin Forms Functional Octameric Complexes (Q27656672) (← links)
• Domain Flexibility Modulates the Heterogeneous Assembly Mechanism of Anthrax Toxin Protective Antigen (Q27675435) (← links)
• Identification of the cellular receptor for anthrax toxin (Q28204415) (← links)
• Anthrax sub-unit vaccine: the structural consequences of binding rPA83 to Alhydrogel®. (Q30407662) (← links)
• Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax (Q30859738) (← links)
• Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components (Q33220213) (← links)
• Effects of spontaneous deamidation on the cytotoxic activity of the Bacillus anthracis protective antigen (Q33224077) (← links)
• Production and characterization of neutralizing monoclonal antibodies that recognize an epitope in domain 2 of Bacillus anthracis protective antigen (Q33251969) (← links)
• Immunogenicity of Bacillus anthracis protective antigen domains and efficacy of elicited antibody responses depend on host genetic background (Q33334776) (← links)
• Neutralizing monoclonal antibodies directed against defined linear epitopes on domain 4 of anthrax protective antigen (Q33496407) (← links)
• Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis (Q33713102) (← links)
• Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits (Q33783323) (← links)
• The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen (Q34068311) (← links)
• Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen (Q34068323) (← links)
• Small molecule inhibitors of anthrax toxin-induced cytotoxicity targeted against protective antigen (Q34092835) (← links)
• A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection (Q34119476) (← links)
• Residue Histidine 669 Is Essential for the Catalytic Activity of Bacillus anthracis Lethal Factor (Q34192622) (← links)
• Identification of new dominant-negative mutants of anthrax protective antigen using directed evolution (Q34403236) (← links)
• Engineering anthrax toxin variants that exclusively form octamers and their application to targeting tumors (Q34580781) (← links)
• 2001: a year of major advances in anthrax toxin research (Q34712623) (← links)
• Cisplatin inhibition of anthrax lethal toxin (Q34973775) (← links)
• Anthrax toxin: a tripartite lethal combination (Q34999660) (← links)
• Anthrax toxins and the host: a story of intimacy (Q35050924) (← links)
• Anthrax toxin: structures, functions and tumour targeting (Q35184740) (← links)
• Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax (Q35217494) (← links)
• Antibodies against anthrax: mechanisms of action and clinical applications (Q35610439) (← links)
• Interactions of high-affinity cationic blockers with the translocation pores of B. anthracis, C. botulinum, and C. perfringens binary toxins (Q36246580) (← links)
• Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidates (Q36478354) (← links)
• Sequential B-cell epitopes of Bacillus anthracis lethal factor bind lethal toxin-neutralizing antibodies (Q37033046) (← links)
• Investigation of new dominant-negative inhibitors of anthrax protective antigen mutants for use in therapy and vaccination (Q37355950) (← links)
• Membrane translocation by anthrax toxin (Q37535082) (← links)
• Clostridial binary toxins: iota and C2 family portraits (Q38037529) (← links)
• Neutralizing antibody and functional mapping of Bacillus anthracis protective antigen-The first step toward a rationally designed anthrax vaccine (Q38649208) (← links)
• Comparative Studies of Actin- and Rho-Specific ADP-Ribosylating Toxins: Insight from Structural Biology. (Q38931721) (← links)
• Functional analysis of Bacillus anthracis protective antigen by using neutralizing monoclonal antibodies (Q40204434) (← links)
• Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody (Q40644450) (← links)
• Pore formation is not associated with macroscopic redistribution of P2X7 receptors. (Q40726523) (← links)
• Exchange characteristics of calcium ions bound to anthrax protective antigen (Q44247948) (← links)
• The role of toxins in Clostridium difficile infection. (Q47734724) (← links)
• Differential requirement for the translocation of clostridial binary toxins: Iota toxin requires a membrane potential gradient (Q57360832) (← links)